Role of prostaglandins in experimental renal disease.
1989
T H Hostetter, and
K A Nath
Division of Renal Diseases, University of Minnesota, Minneapolis.
UI
MeSH Term
Description
Entries
D006984
Hypertrophy
General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
Hypertrophies
D007668
Kidney
Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.
Kidneys
D007674
Kidney Diseases
Pathological processes of the KIDNEY or its component tissues.
Disease, Kidney,Diseases, Kidney,Kidney Disease
D011453
Prostaglandins
A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes.
Prostaglandin,Prostanoid,Prostanoids
D012079
Renal Circulation
The circulation of the BLOOD through the vessels of the KIDNEY.
Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA.
April 2010,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,